For example, a multi-modal DL framework that utilizes the entire ADNI series, including T1-weighted MRI and 18F-FDG PET from the ADNI1 dataset, as well as Aβ PET and tau protein PET from ADNI2 and ADNI3 datasets, achieved a balanced accuracy of 1.00 in the AD versus CN task and 0.76 in the MCI versus CN task [687]. The gene discussed is MAPT; the disease is Alzheimer disease.